6CM
683 Capital Management Portfolio holdings
AUM
$986M
This Quarter Return
+8.16%
1 Year Return
+26.79%
3 Year Return
+135.86%
5 Year Return
+188.43%
10 Year Return
+750.26%
AUM
$1.12B
AUM Growth
+$1.12B
(+0.77%)
Cap. Flow
-$31.5M
Cap. Flow
% of AUM
-2.81%
Top 10 Holdings %
Top 10 Hldgs %
33.85%
Holding
340
New
26
Increased
24
Reduced
79
Closed
54
Top Buys
| 1 |
BorgWarner
BWA
|
$27M |
| 2 |
JPMorgan Chase
JPM
|
$19.2M |
| 3 |
Caesars Entertainment
CZR
|
$17.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$16.9M |
| 5 |
Protagonist Therapeutics
PTGX
|
$13.4M |
Top Sells
| 1 |
Enova International
ENVA
|
$29.8M |
| 2 |
MasterBrand
MBC
|
$18.9M |
| 3 |
RKTA
Rocket Internet Growth Opportunities Corp.
RKTA
|
$15M |
| 4 |
IAC Inc
IAC
|
$12.7M |
| 5 |
DRAY
Macondray Capital Acquisition Corp. I Class A Ordinary Shares
DRAY
|
$10.2M |
Sector Composition
| 1 | Financials | 31.75% |
| 2 | Healthcare | 20.44% |
| 3 | Consumer Discretionary | 12.13% |
| 4 | Energy | 7.34% |
| 5 | Materials | 6.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PANA
26
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
| $15.1M | 1.13% |
1,480,000
| – | – |
|
27
Builders FirstSource
BLDR
$15.1B
| $14.2M | 1.06% |
160,000
-80,000
| -33% | -$7.1M |
|
|
28
MasterBrand
MBC
$1.58B
| $14.1M | 1.05% |
1,750,000
-2,350,000
| -57% | -$18.9M |
|
29
TG Therapeutics
TGTX
$5.03B
| $11.7M | 0.87% |
775,000
-475,000
| -38% | -$7.14M |
|
|
GTAC
30
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
| $10.8M | 0.81% |
1,035,000
-500,000
| -33% | -$5.23M |
|
31
Apellis Pharmaceuticals
APLS
$3.51B
| $10.6M | 0.79% |
160,000
-15,000
| -9% | -$989K |
|
|
ARYE
32
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
| $10.2M | 0.76% |
1,000,000
| – | – |
|
33
Brighthouse Financial
BHF
$2.55B
| $9.92M | 0.74% |
+225,000
| New | +$9.92M |
|
34
Ryder
R
$7.59B
| $9.82M | 0.73% |
+110,000
| New | +$9.82M |
|
35
Viking Therapeutics
VKTX
$3.02B
| $9.66M | 0.72% |
580,000
+551,000
| +1,900% | +$9.17M |
|
36
Phathom Pharmaceuticals
PHAT
$843M
| $9.46M | 0.7% |
1,325,500
-24,500
| -2% | -$175K |
|
37
Immatics
IMTX
$662M
| $9.21M | 0.69% |
1,334,937
+34,937
| +3% | +$241K |
|
|
CRESY
38
Cresud
CRESY
$583M
| $9M | 0.67% |
1,412,967
-12,033
| -0.8% | -$76.7K |
|
39
MeiraGTx Holdings
MGTX
$590M
| $8.66M | 0.65% |
1,675,000
-25,000
| -1% | -$129K |
|
40
Syndax Pharmaceuticals
SNDX
$1.39B
| $8.24M | 0.61% |
390,000
-180,000
| -32% | -$3.8M |
|
41
Iovance Biotherapeutics
IOVA
$800M
| $8.1M | 0.6% |
1,325,000
+325,000
| +33% | +$1.99M |
|
42
Teck Resources
TECK
$16.5B
| $7.85M | 0.58% |
215,000
+80,000
| +59% | +$2.92M |
|
|
VMCA
43
DELISTED
Valuence Merger Corp. I Class A Ordinary Shares
VMCA
| $7.37M | 0.55% |
700,000
| – | – |
|
|
ORIA
44
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
| $7.15M | 0.53% |
699,000
-500,000
| -42% | -$5.12M |
|
|
DEVS
45
DevvStream Corp. Common Stock
DEVS
$7.97M
| $6.88M | 0.51% |
661,969
| – | – |
|
|
AFMD
46
DELISTED
Affimed
AFMD
| $6.71M | 0.5% |
9,000,000
| – | – |
|
|
ITOS
47
DELISTED
iTeos Therapeutics
ITOS
| $6.53M | 0.49% |
480,000
+330,000
| +220% | +$4.49M |
|
48
Citigroup
C
$175B
| $6.33M | 0.47% |
135,000
+40,000
| +42% | +$1.88M |
|
49
Cardlytics
CDLX
$47.4M
| $6.2M | 0.46% |
1,825,000
+75,000
| +4% | +$255K |
|
|
CNR
50
Core Natural Resources, Inc.
CNR
$3.67B
| $5.83M | 0.43% |
+100,000
| New | +$5.83M |
|